STOCK TITAN
  1. Home
  2. Sec-filings
  3. AAPG
  4. [Form 3] ASCENTAGE PHARMA GROUP INTERNATIONAL Initial Statement of Beneficial Ownership

Ascentage Pharma (AAPG) director discloses options and RSUs in initial Form 3

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

ASCENTAGE PHARMA GROUP INTERNATIONAL director Ye Changqing filed an initial ownership report showing equity awards in the company. The filing lists stock options tied to 56,550 Ordinary Shares with an exercise price of $8.1400 per share, expiring on November 26, 2035. These options vest in four equal parts on each of November 26, 2026, 2027, 2028 and 2029.

The filing also reports 66,550 restricted stock units, each representing one Ordinary Share. These RSUs vest in four equal annual installments on the same dates, from November 26, 2026 through 2029, and have no expiration date.

Positive

  • None.

Negative

  • None.
Insider Ye Changqing
Role Director
Type Security Shares Price Value
holding Options -- -- --
holding Restricted stock units -- -- --
Holdings After Transaction: Options — 56,550 shares (Direct); Restricted stock units — 66,550 shares (Direct)
Footnotes (1)
  1. The stock options vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029. The exercise price for the stock options is in HKD, and the exercise price included in the table represents conversion to USD based on the exchange rate on the date of grant. Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029 and have no expiration date.
Understanding Insider Trading Forms →
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Ye Changqing
(Last)(First)(Middle)
700 KING FARM BLVD
STE 510
(Street)
ROCKVILLE MARYLAND 20850
(City)(State)(Zip)
UNITED STATES
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026		3. Issuer Name and Ticker or Trading Symbol
ASCENTAGE PHARMA GROUP INTERNATIONAL [ AAPG ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Options (1)11/26/2035Ordinary Shares56,550$8.14(2)D
Restricted stock units (3) (3)Ordinary Shares66,550$0D
Explanation of Responses:
1. The stock options vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029.
2. The exercise price for the stock options is in HKD, and the exercise price included in the table represents conversion to USD based on the exchange rate on the date of grant.
3. Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029 and have no expiration date.
Remarks:
Changqing Ye03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does the AAPG Form 3 filed by Ye Changqing report?

The Form 3 reports Ye Changqing’s initial beneficial ownership in ASCENTAGE PHARMA GROUP INTERNATIONAL, including stock options and restricted stock units that give rights to receive Ordinary Shares over a multi-year vesting schedule starting in November 2026.

How many stock options does Ye Changqing hold in AAPG?

Ye Changqing holds stock options linked to 56,550 Ordinary Shares of ASCENTAGE PHARMA GROUP INTERNATIONAL. These options vest in four equal annual installments from November 26, 2026 through November 26, 2029 and expire on November 26, 2035, if not exercised.

What is the exercise price of Ye Changqing’s AAPG stock options?

The exercise price of the reported stock options is $8.1400 per Ordinary Share. The price was originally set in Hong Kong dollars, then converted to U.S. dollars using the exchange rate on the grant date, according to the Form 3 footnote.

How many restricted stock units does Ye Changqing report for AAPG?

The Form 3 shows 66,550 restricted stock units, each representing one Ordinary Share of ASCENTAGE PHARMA GROUP INTERNATIONAL. These RSUs vest in four equal annual tranches on November 26 of 2026, 2027, 2028 and 2029 and do not have an expiration date.

Do the equity awards in AAPG’s Form 3 have vesting schedules?

Yes. Both the stock options and restricted stock units vest in four equal annual installments. The vesting dates are November 26, 2026, 2027, 2028 and 2029, meaning Ye Changqing’s rights to the underlying Ordinary Shares increase gradually over that four-year period.